Supplement: MilliporeSigma Sees Opportunity in Continuous Processing
From the GEN Sounds of Science Podcast
Why CAR-T Therapies Don’t Work for Everyone Yet
Selecting the Best Type of T Cells for CAR-T May be Key to the Overall Efficacy of the Therapies
Cell-Centered: Scientists Embrace Cell-Replacement Therapy for Type 1 Diabetes
Forming Beta Cells from Stem Cells
GEN Roundup: Multiplex Immunoassays Bring the Array, Not the Disarray
Get Multiplex Immunoassay Advice from GEN's Expert Panel
For full access to this article login to GEN Select now.
Downstream Bottlenecks: Are They Myth or Reality?
Throughput Isn’t Where It Should Be, and There Is Some Disagreement as to Why
- Like the story of the blind men describing an elephant, the answer to whether a downstream bioprocessing bottleneck exists is largely one of perception. “The situation is even worse than it was two years ago,” according to Uwe Gottschalk, Ph.D., vp of purification technology, a business unit of Sartorius ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.